Curaleaf

Today, we announced our intention to acquire Aurora Cannabis Inc. (NASDAQ: ACB), creating the global cannabis industry leader. This combination would provide Aurora shareholders with immediate value and both Aurora and Curaleaf shareholders with the opportunity to participate in the value creation of the leading global cannabis company, with an expanded international footprint, a robust end-to-end supply chain, and enhanced opportunities for growth, profitability, and access to global capital markets. We believe Aurora shareholders should have the opportunity to evaluate a proposal that delivers compelling value while enabling them to participate in a stronger combined company. We stand ready to engage constructively with Aurora’s Board to advance this value-maximizing transaction. Details: https://lnkd.in/eqRwUgjw

Our Q2 2026 financial and operational results are now available, reflecting continued progress as we execute on our Built for Growth strategy and position Curaleaf for long-term success. Join us today at 5PM ET for our earnings conference call and Q&A: https://lnkd.in/exwtVBkE

Curaleaf has reached another milestone in Florida with the opening of our 75th dispensary in the state, located in Boynton Beach! As we continue expanding access across the state, we're focused on delivering trusted products, exceptional service, and a seamless experience for patients. Join us for the grand opening on July 31 and August 1.  https://lnkd.in/gvMBheXH

Curaleaf is growing in Florida with the opening of our 74th dispensary in Edgewater! We look forward to welcoming patients and the community to our two-day grand opening celebration on July 24 and 25. Details: https://lnkd.in/eB99zgfy

We're proud to become the first company to register standardized cannabis preparations under Spain's new regulatory framework. This achievement reflects years of investment in science, quality, and our commitment to expanding patient access. https://lnkd.in/ebY-pUqW

Curaleaf marks another capital markets milestone as exchange-traded options on our shares are expected to begin trading on the Montréal Exchange on July 13. Details: https://lnkd.in/gMpMq238

Concentrate enthusiasts know that the details matter. This 710, we’re highlighting the quality and craftsmanship behind Grassroots concentrates, created for those who appreciate premium experiences and unique strain profiles. https://lnkd.in/gYTwYheC

We're thrilled to officially welcome Torsten Greif and Faith Charles, JD to Curaleaf's Board of Directors. Together, they bring deep experience across international business, corporate governance, regulatory affairs, and the life sciences. Their expertise will strengthen our Board as we continue to expand our global footprint. We also extend our sincere thanks to Mitch Kahn for his years of service and valuable contributions to Curaleaf. 

Join us on August 5 at 5:00 p.m. ET for our second quarter 2026 earnings call. Details: https://lnkd.in/e_Wf3Z5X

Today we are excited to announce the launch of the Curaleaf Education Platform in the UK. Despite legalisation in 2018, most healthcare professionals have never received structured training in this area. That gap doesn't just affect clinical confidence, it shapes patient conversations, referral decisions and prescribing pathways. The Curaleaf Education Platform is a free, CPD-accredited resource, built to address the gap for GPs, pharmacists, consultants and other healthcare professionals involved in patient care, with structured learning pathways that translate evidence into practical clinical knowledge. Dr Simon Erridge commented, "What we’ve built with the Education Platform is what I wish I’d had access to when I started working in this field: clear, evidence-led modules that cut through the noise and give clinicians the confidence to integrate medical cannabis into their practice responsibly. The response from the healthcare community has shown us there’s a real appetite for this kind of structured, accredited learning" We look forward to expanding and providing localised education resources globally. The platform reflects Curaleaf International’s ongoing commitment to research, innovation and responsible development within medical cannabis. The CPD Certification Service Curaleaf Curaleaf Clinic Curaleaf Laboratories Third City Beth Sweet-Escott Inara Sihat Medico Digital #medicalcannabisUK #medicalcannabiseducation #CPDcertification #UKhealthcare